Loading...
Macrophage migration inhibitory factor promotes resistance to MEK blockade in KRAS mutant colorectal cancer cells
Although MEK blockade has been highlighted as a promising antitumor drug, it has poor clinical efficacy in KRAS mutant colorectal cancer (CRC). Several feedback systems have been described in which inhibition of one intracellular pathway leads to activation of a parallel signaling pathway, thereby d...
Na minha lista:
| Udgivet i: | Mol Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6068346/ https://ncbi.nlm.nih.gov/pubmed/29896883 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12345 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|